Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    10986965 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Conditions: Metastatic Melanoma;   Renal Cell Cancer
Intervention: Biological: aldesleukin

Study has passed its completion date and status has not been verified in more than two years.